Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2012
11/07/2012CN101721699B Application of VEGF receptor fusion protein in preparing medicament for treating inflammatory reaction accompanying increase of VEGF
11/07/2012CN101721529B Composition with functions of clearing heat and detoxicating and preparation method thereof
11/07/2012CN101648000B Application of cobrotoxin in preparing medicine for treating arthritis
11/07/2012CN101563074B Acetaminophen / ibuprofen combinations
11/07/2012CN101536994B Method for preparing hybrid nanofiber membrane capable of loading drug
11/07/2012CN101518521B New medical application of cedrol
11/06/2012US8304453 Composition comprising at least one alkanolamide to inhibit migration of langerhans cells and uses therof
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304409 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
11/06/2012CA2495685C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
11/06/2012CA2489208C Interleukin-6 suppressive agent
11/01/2012WO2012149454A2 Tolerogenic synthetic nanocarriers coupled to cd1d-restricted antigens and methods of use
11/01/2012WO2012149265A2 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
11/01/2012WO2012149259A1 Tolerogenic synthetic nanocarriers to reduce antibody responses
11/01/2012WO2012149218A2 Antagonists of trpv1 receptor
11/01/2012WO2012149186A2 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
11/01/2012WO2012148548A1 N-substituted oxazinopteridines and oxazinopteridinones
11/01/2012WO2012148547A1 Compositions and methods for treating inflammatory conditions of the ocular surface
11/01/2012WO2012148247A2 Pharmaceutical composition containing oleanolic acid acetate as an active ingredient for preventing or treating tlr- or il-6-mediated diseases
11/01/2012WO2012148002A1 Method for modulating ion transporter
11/01/2012WO2012147986A1 Stable pharmaceutical composition
11/01/2012WO2012147705A1 Therapeutic agent for inflammatory respiratory diseases comprising trehalose
11/01/2012WO2012146800A1 Use of diterpenoid compounds as antiinflammatory and antitumour agents
11/01/2012WO2012146362A1 Triazole compounds as potential anti-inflammatory agents
11/01/2012WO2012146057A1 Curcuminoid injection solution and intravenous injection
11/01/2012WO2012145981A1 Adamantane or adamantane-like compounds as antitumor agents
11/01/2012WO2012087160A3 Anti-inflammatory proteins and methods of preparation and use thereof
11/01/2012WO2012038850A8 Pyrimidones for treatment of potassium channel related diseases
11/01/2012US20120277319 Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety
11/01/2012US20120277299 Method for modulating ion transporter
11/01/2012US20120277293 Immunostimulatory Method
11/01/2012US20120277292 ANTISENSE OLIGONUCLEOTIDES AGAINST cPLA2, COMPOSITIONS AND USES THEREOF
11/01/2012US20120277289 Activity generating delivery molecules
11/01/2012US20120277279 Non-Steroidal Glucocorticoid Inhibitors and Their Use in Treating Inflammation, Allergy and Auto-Immune Conditions
11/01/2012US20120277278 Phenylbutazone carrier formulation showing increased bioactivity in animals
11/01/2012US20120277277 Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal
11/01/2012US20120277267 Method of managing or treating pain
11/01/2012US20120277259 Substituted benzofused derivatives and their use as vanilloid receptor ligands
11/01/2012US20120277256 Frequency modulated drug delivery (fmdd)
11/01/2012US20120277255 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277254 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277247 Novel compound useful for the treatment of degenerative and inflammatory diseases
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277238 Pharmaceutical composition containing fused hetero-ring derivative
11/01/2012US20120277228 Novel Azaheterocyclic Compounds
11/01/2012US20120277227 Benzimidazole inhibitors of leukotriene production
11/01/2012US20120277226 Benzimidazole inhibitors of leukotriene production
11/01/2012US20120277225 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277220 5 OXO-5,8-DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS CAMKII KINASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES
11/01/2012US20120277219 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/01/2012US20120277215 Organic Compounds
11/01/2012US20120277205 Derivatives of n-[(1h-pyrazol-1-yl)aryl]-1h-indole or 1h-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics
11/01/2012US20120277198 Polyhydroxylated bile acids for treatment of biliary disorders
11/01/2012US20120277194 Aminopropanol derivatives
11/01/2012US20120277174 New macrolides and their use
11/01/2012US20120277173 Stabilized anthocyanin compositions
11/01/2012US20120277166 Conotoxin peptides useful as inhibitors of neuronal amine transporters
11/01/2012US20120277164 Gadd45beta targeting agents
11/01/2012US20120277146 Compounds For Enzyme Inhibition
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120276224 Compound comprising extracts or fractions of chrysanthemum boreale makino having anti-inflammation activity
11/01/2012US20120276215 Therapeutic Conditioned Media
11/01/2012US20120276212 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
11/01/2012US20120276193 Agents, Uses and Methods
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276191 Treatment and Diagnosis of Macrophage Mediated Disease
11/01/2012US20120276172 Polymeric materials for medical devices
11/01/2012US20120276160 Tolerogenic synthetic nanocarriers for regulating innate immune responses
11/01/2012US20120276159 Tolerogenic synthetic nanocarriers
11/01/2012US20120276158 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
11/01/2012US20120276155 Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cells
11/01/2012US20120276143 Probiotic bifidobacterium strain
11/01/2012US20120276133 Tolerogenic synthetic nanocarriers for inducing regulatory b cells
11/01/2012US20120276126 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/01/2012US20120276119 CD37-Binding Molecules and Immunoconjugates Thereof
11/01/2012US20120276112 Anti-factor xi monoclonal antibodies and methods of use thereof
11/01/2012US20120276111 Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor
11/01/2012US20120276110 Modulation of Pathogenic Monocytes
11/01/2012US20120276108 Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases
11/01/2012US20120276105 Use of cytokine expression to predict skin inflammation; methods of treatment
11/01/2012US20120276102 Methods of treatment utiliziing binding proteins of the interleukin-21 receptor
11/01/2012US20120276095 B7-h4 fusion proteins and methods of use thereof
11/01/2012US20120276091 Human Recombinant Monoclonal Antibody That Specifically Binds to VCAM-1 and Inhibits Adhesion and Transmigration Between Leukocytes and Endothelial Cells
11/01/2012US20120276087 Methods and compositions using pde4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
11/01/2012US20120276067 Assay for the Prediction of Therapeutic Effectiveness of Mesenchymal Stromal Cells, and Methods of Using Same
11/01/2012US20120276066 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same
11/01/2012US20120276049 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
11/01/2012US20120276018 Alkaloid ester and carbamate derivatives and medicinal compositions thereof
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012CA2841452A1 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use
11/01/2012CA2834532A1 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
11/01/2012CA2834527A1 Tolerogenic synthetic nanocarriers to reduce antibody responses
11/01/2012CA2834028A1 Stable pharmaceutical composition
11/01/2012CA2827770A1 N-substituted oxazinopteridines and oxazinopteridinones
10/2012
10/31/2012EP2518056A1 Seven-membered ring compound and pharmaceutical use therefor
10/31/2012EP2518049A2 Aminoalcohol derivatives and their therapeutic use
10/31/2012EP2517711A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
10/31/2012EP2516647A1 Molecule for treating an inflammatory disorder
10/31/2012EP2516458A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy
10/31/2012EP2516434A1 Fused heteroaromatic pyrrolidinones as syk inhibitors
1 ... 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... 1272